Welcome to our dedicated page for ACME UNITED SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ACME UNITED's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ACME UNITED's regulatory disclosures and financial reporting.
ACME UNITED CORP (ACU) reported that Brian S. Olschán, its President, COO and a director, sold a total of 7,308 shares of common stock on August 18, 2026 in open-market or private transactions. The sales consisted of 4,000 shares at $61.36 per share and 3,308 shares at $61.63 per share. The filing does not state Brian Olschán's holdings after these transactions, and the Rule 10b5-1 trading plan checkbox was not marked as applicable.
ACME United Corp. insider Brian Olschan filed a Form 144 indicating an intention to sell 7,308 shares of common stock through Fidelity Brokerage Services LLC on the AMEX. The filing lists an aggregate market value of $453,096.00 for these planned sales, with 3,833,823 shares of common stock outstanding. The shares to be sold are tied to a stock award from the issuer dated August 14, 2026 and are characterized as compensation. The notice also details multiple open-market sales of common stock by Olschan during the prior three months, including transactions on May 27–28 and August 3–12, 2026.
ACME UNITED CORP insider Brian S. Olschran, President and COO, reported a set of equity transactions on August 13, 2026 tied to an option exercise. He exercised an Employee Stock Option for 20,000 shares of common stock at an exercise price of $19.48 per share, leaving 206,700 option shares outstanding from this award. In connection with this exercise, he acquired 20,000 shares of common stock and 12,692 shares of common stock were delivered or withheld at a reference price of $60.77 per share for payment of the exercise price or tax liability. The company notes the option exercise was effected on a net share settlement basis, and the transactions were not reported as made under a Rule 10b5-1 trading plan.
ACME UNITED CORP (ACU) director Brian Barker reported selling 3,821 shares of common stock on 2026-08-13 in a sale classified as an open market or private transaction at $60.50 per share. Following this transaction, he reported owning 0 shares of ACU common stock directly. The Rule 10b5-1 trading plan box was unchecked.
ACME UNITED CORP director Brian Barker reported option-related transactions on Common Stock dated 2026-08-11. He exercised 4,000 Employee Stock Options at $21.20 per share, resulting in 17,500 derivative securities (options) remaining after the exercise. The exercise generated 4,000 Common Shares, and 1,479 Common Shares at $57.35 per share were delivered or withheld for payment of exercise price or tax liability. According to a footnote, the option exercise was effected on a net share settlement basis.
ACME United Corp director and President/COO Brian S. Olschán reported a series of open-market or private sales of the company’s common stock. Between August 3 and August 12, 2026, he sold a total of 10,909 shares in seven transactions at reported per-share prices between $55.51 and $58.39. The Rule 10b5-1 trading plan checkbox was not marked as applicable, and post-transaction share holdings are not disclosed in this report.
ACME UNITED CORP director Rex Lynn Davidson reported several equity transactions. On 2026-08-05, he exercised 5,000 Employee Stock Options at $28.20 per share, receiving 5,000 shares of common stock, while 2,544 shares were delivered or withheld to cover the exercise price or tax liability on a net share settlement basis. Following this exercise, 26,500 options remained outstanding. On 2026-08-10, he sold 3,684 shares of common stock at $56.48 per share in an open-market or private sale.
Acme United Corporation filed to permit the public sale of 3,684 shares of its common stock through UBS Financial Services Inc. The proposed sale relates to shares listed on the NYSE, with an aggregate market value of $207,861.09 based on the filer’s calculation.
The notice also lists prior acquisitions and open-market transactions in Acme United common stock, including a stock grant of 2,456 shares on August 5, 2026 and several smaller open-market purchases in 2022.
Acme United Corporation reported strong top-line growth for the quarter ended June 30, 2026, led by first aid/medical products and the newly acquired My Medic direct-to-consumer business. Consolidated net sales were $62,716,000 versus $53,996,000 a year earlier, and six‑month sales were $115,017,000 versus $99,954,000.
Gross profit improved to $26,688,000 or 42.6% of sales for the quarter, helped by the higher-margin My Medic line. However, SG&A rose to $19,858,000 (31.7% of sales) due to My Medic advertising and higher personnel costs, and tariff-affected inventory pressured results. Operating income was $6,830,000 for the quarter and $8,574,000 year-to-date, close to prior-year levels. Net income was $5,051,000 for the quarter and $6,034,000 for six months, with diluted EPS of $1.22 and $1.46, respectively.
Operating cash flow strengthened to $10,887,000 for the first half, supporting the $18,500,000 My Medic asset acquisition and lifting total assets to $200,645,000 and equity to $121,302,000. Revolving credit borrowings increased to $22,637,000, and the company subsequently replaced its facility with a new $65,000,000 syndicated credit line maturing in 2029, maintaining ample liquidity while managing higher tariffs and geopolitical supply-chain risks.
Brian Olschan filed a Form 144 indicating an intention to sell 10,909 shares of ACME United Corp common stock through Fidelity Brokerage Services LLC on the AMEX, with an aggregate market value of $620,285.74. The disclosure notes that ACME United Corp had 3,810,359 shares outstanding. The shares to be sold were received as a stock award from the issuer on 07/24/2026 as compensation. The notice also lists sales during the past three months: 1,578 shares sold for $66,241.68 on 05/27/2026 and 3,255 shares sold for $136,707.51 on 05/28/2026.